Stein Evan A
University of Cincinnati, Highland Heights, KY 41076, USA.
Postgrad Med. 2002 Oct;112(4 Suppl):12-7. doi: 10.3810/pgm.10.2002.suppl20.106.
The new treatment guidelines issued by the Third National Cholesterol Education Program Adult Treatment Panel III depart from the recommendations of the previous edition, the ATP II, in a number of significant ways. Perhaps the most significant are the lowering of the target level of low-density lipoprotein to <100 mg/dL and the introduction of the coronary heart disease risk equivalent. As a result, many more individuals have been identified as requiring intervention, and others will require more aggressive modalities, including cholesterol lowering pharmacotherapy.
